Attached files
| file | filename |
|---|---|
| EX-4.95 - EXHIBIT 4.95 - AMYRIS, INC. | exh_495.htm |
| 10-Q - FORM 10-Q - AMYRIS, INC. | f10q_081417p.htm |
| EX-32.02 - EXHIBIT 32.02 - AMYRIS, INC. | exh_3202.htm |
| EX-32.01 - EXHIBIT 32.01 - AMYRIS, INC. | exh_3201.htm |
| EX-31.02 - EXHIBIT 31.02 - AMYRIS, INC. | exh_3102.htm |
| EX-31.01 - EXHIBIT 31.01 - AMYRIS, INC. | exh_3101.htm |
| EX-10.09 - EXHIBIT 10.09 - AMYRIS, INC. | exh_1009.htm |
| EX-10.08 - EXHIBIT 10.08 - AMYRIS, INC. | exh_1008.htm |
| EX-10.01 - EXHIBIT 10.01 - AMYRIS, INC. | exh_1001.htm |
| EX-4.96 - EXHIBIT 4.96 - AMYRIS, INC. | exh_496.htm |
| EX-4.94 - EXHIBIT 4.94 - AMYRIS, INC. | exh_494.htm |
| EX-4.93 - EXHIBIT 4.93 - AMYRIS, INC. | exh_493.htm |
| EX-4.92 - EXHIBIT 4.92 - AMYRIS, INC. | exh_492.htm |
| EX-4.91 - EXHIBIT 4.91 - AMYRIS, INC. | exh_491.htm |
| EX-4.81 - EXHIBIT 4.81 - AMYRIS, INC. | exh_481.htm |
| EX-4.69 - EXHIBIT 4.69 - AMYRIS, INC. | exh_469.htm |
| EX-4.54 - EXHIBIT 4.54 - AMYRIS, INC. | exh_454.htm |
| EX-4.53 - EXHIBIT 4.53 - AMYRIS, INC. | exh_453.htm |
| EX-4.27 - EXHIBIT 4.27 - AMYRIS, INC. | exh_427.htm |
Exhibit 10.04
CONFIDENTIAL TREATMENT REQUESTED. CERTAIN PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND, WHERE APPLICABLE, HAVE BEEN MARKED WITH AN ASTERISK TO DENOTE WHERE OMISSIONS HAVE BEEN MADE. THE CONFIDENTIAL MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
April 23, 2017
STRICTLY PRIVATE AND CONFIDENTIAL
Delivered by Hand
Mr. Lie Quan Chen
Chairman of the Board
Nenter & Co., Inc.
197 Oriental Road, High Tech Development Zone
Jingzhou City, Hubei Province
People’s Republic of China
Re: Termination of Cooperation Agreement
Dear Mr. Chen:
Reference is made to the Cooperation Agreement, dated as of October 26, 2016 (the “Cooperation Agreement”), by and between Amyris, Inc. and Nenter & Co., Inc. (“Nenter”) concerning Vitamin A Products. Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed thereto in the Cooperation Agreement.
The Parties agree to terminate the Cooperation Agreement, effective immediately. Nenter hereby releases and disclaims any and all (i) license, right, claim and interest in or to Amyris Intellectual Property useful to the production of [*] Products, and (ii) right to purchase [*] Products. In consideration thereof, Amyris shall pay a cash payment to Nenter by wire transfer of immediately available funds in an amount equal to two million five hundred thousand dollars ($2,500,000), such payment to be made within sixty days hereof.
Nothing in this letter shall be deemed to modify other agreements between the Parties, or any right or remedy thereunder, all of which are hereby expressly reserved.
| Sincerely, | Accepted and agreed to: | |||
| Amyris, Inc. | Nenter & Co., Inc. | |||
| By: | /s/ John Melo | By: | /s/ Lie Quan Chen | |
| Name: | John Melo | Name: | ||
| Title: | President and Chief Executive Officer | Title: | ||
[*] Certain portions denoted with an asterisk have been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.